L01FF02 - pembrolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
J01DI54 - ceftolozane and beta-lactamase inhibitor : Belongs to the class of other cephalosporins and penems. Used in the systemic treatment of infections.
L01FF02 - pembrolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
J01DI54 - ceftolozane and beta-lactamase inhibitor : Belongs to the class of other cephalosporins and penems. Used in the systemic treatment of infections.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education